Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endoplasmic reticulum P5A-ATPase (ATP13A1) is an evolutionarily conserved P-type ATPase enzyme localized in the endoplasmic reticulum (ER) membrane[2][1][3][6]. It functions as a protein dislocase, removing mislocalized mitochondrial tail-anchored proteins and substrates with misoriented N-terminal transmembrane domains from the ER, thus maintaining proteome quality and correct protein topogenesis[1][2][6][4]. ATP13A1 also contributes to cellular manganese ion homeostasis by mediating manganese transport into the ER, affecting various manganese-dependent processes[3][5]. Dysfunction or absence of ATP13A1 impairs protein folding, increases ER stress, disrupts manganese homeostasis, and may predispose to neurodegenerative diseases[5][6][3]. It is part of the P5A subfamily of P-type ATPases and is not currently known to be the direct target of any approved therapeutics or drugs.
ATP-driven transport (of cations, especially manganese) and protein dislocation/removal based on substrate recognition; maintains protein and ion homeostasis in the ER
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endoplasmic reticulum P5A-ATPase (ATP13A1).